(Q43251148)

English

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

scientific article published on 30 October 2009

In more languages
default for all languages
No label defined

No description defined

Statements

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma (English)
Sandra Croockewit
Marinus H van Oers
Peter von dem Borne
Pierre Wijermans
Shulamiet Wittebol
Michel Delforge
Henriëtte Berenschot
Kon-Siong G Jie
Marinus van Marwijk-Kooy
Rianne van Ammerlaan
Dutch-Belgian Hemato-Oncology Group (HOVON)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit